Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Prostate Cancer

  Free Subscription


25.05.2026

2 BJU Int
2 BMC Cancer
1 Br J Radiol
1 Eur Urol
2 Int J Urol
1 J Nucl Med
2 J Urol
1 Oncogene
1 Oncol Rep
1 PLoS One
1 Radiol Imaging Cancer


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BJU Int

  1. LU S, Roque C, Saranchuk J, Ahmad AE, et al
    Active surveillance for intermediate risk prostate cancer: the Manitoba Prostate Center experience.
    BJU Int. 2026 May 20. doi: 10.1111/bju.70318.
    PubMed         Abstract available

  2. MESZES-TOTH A, Gyulai AT, Izsak B, Erdelyi AE, et al
    Preliminary results and experiences of fluorescence confocal microscopy using the Histolog(R) Scanner in prostate cancer diagnostics: a feasibility study.
    BJU Int. 2026 May 15. doi: 10.1111/bju.70316.
    PubMed         Abstract available


    BMC Cancer

  3. SMART TF, Bass JJ, Crossland H, Cox J, et al
    A cohort study investigating differences in skeletal muscle mitochondrial function between prostate cancer patients and healthy controls.
    BMC Cancer. 2026 May 21. doi: 10.1186/s12885-026-16164.
    PubMed         Abstract available

  4. ZHANG YY, Wang C, Wang HQ, Shen J, et al
    The expression significance and non-invasive detection of REEP6 and REEP5 in prostate cancer.
    BMC Cancer. 2026 May 18. doi: 10.1186/s12885-026-16191.
    PubMed         Abstract available


    Br J Radiol

  5. BOSSI CROCI R, Sapoval M, Dariane C, Pellerin O, et al
    PI-RADS 3-5 lesions MRI pattern after Prostate Artery Embolization.
    Br J Radiol. 2026 Mar 14:tqag062. doi: 10.1093.
    PubMed         Abstract available


    Eur Urol

  6. AL-MONAJJED R, Albers P, van Poppel H, Bratt O, et al
    From Evidence to Implementation: How Should We Screen for Prostate Cancer in the Modern Era?: Editorial to: Nguyen DD, Tadayon B, Lin L, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-spe
    Eur Urol. 2026 May 20:S0302-2838(26)02158-5. doi: 10.1016/j.eururo.2026.
    PubMed        


    Int J Urol

  7. HOSHI S, Izumi K, Meguro S, Shima T, et al
    Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCa.
    Int J Urol. 2026;33:e70511.
    PubMed         Abstract available

  8. KASHIWAGI E, Ushijima M, Ueda S, Tsubonuma Y, et al
    Reduced Uncoupling Protein 1 Expression in Periprostatic Adipose Tissue and Its Association With Higher Prostate Cancer Grade.
    Int J Urol. 2026;33:e70506.
    PubMed         Abstract available


    J Nucl Med

  9. GUBERINA N, Karpinski MJ, Guberina M, Hoberuck S, et al
    Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registry.
    J Nucl Med. 2026 May 21:jnumed.125.271770. doi: 10.2967/jnumed.125.271770.
    PubMed         Abstract available


    J Urol

  10. MIYAJIMA K, Miszczyk M, Matsukawa A, Roessler N, et al
    First-Line Systemic Treatments for Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-analysis.
    J Urol. 2026 May 22:101097JU0000000000005131. doi: 10.1097/JU.0000000000005131.
    PubMed         Abstract available

  11. DAS A, Corkum MT, Morgan SC
    From Guidance to Practice: Understanding the 2026 AUA/ASTRO Clinically Localized Prostate Cancer Guideline Amendment.
    J Urol. 2026 May 19:101097JU0000000000005129. doi: 10.1097/JU.0000000000005129.
    PubMed        


    Oncogene

  12. CHENG B, Gong L, Xu H, Wang Z, et al
    The microbiome across the prostate disease continuum: from health and BPH to prostatitis/CPPS and cancer.
    Oncogene. 2026;45:1955-1969.
    PubMed         Abstract available


    Oncol Rep

  13. LU L, Wu K, Wang Z, Yang R, et al
    SRRT promotes prostate cancer progression and serves as a prognostic biomarker through STAT3 pathway activation.
    Oncol Rep. 2026;56:129.
    PubMed         Abstract available


    PLoS One

  14. LUMBRERAS B, Parker LA, Alonso-Coello P, Caballero-Romeu JP, et al
    Disparities in prostate cancer screening practices among general practitioners and urologists (PROSHADE study): A cross-sectional study.
    PLoS One. 2026;21:e0349758.
    PubMed         Abstract available


    Radiol Imaging Cancer

  15. ALI FZ
    New Standardized PSMA PET Reporting Framework for Long-Term Survival Prediction in Prostate Cancer.
    Radiol Imaging Cancer. 2026;8:e269012.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum